A detailed history of Vanguard Group Inc transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 177,922 shares of NXL stock, worth $192,155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
177,922
Previous 176,582 0.76%
Holding current value
$192,155
Previous $162,000 18.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026

BUY
$0.88 - $1.86 $1,179 - $2,492
1,340 Added 0.76%
177,922 $192,000
Q3 2025

Nov 07, 2025

BUY
$0.72 - $1.26 $12,026 - $21,047
16,704 Added 10.45%
176,582 $162,000
Q1 2025

May 09, 2025

BUY
$1.91 - $3.72 $65,738 - $128,034
34,418 Added 27.43%
159,878 $311,000
Q4 2024

Feb 11, 2025

BUY
$0.62 - $4.36 $58,081 - $408,444
93,680 Added 294.78%
125,460 $345,000
Q2 2024

Aug 13, 2024

BUY
$0.61 - $2.96 $19,385 - $94,068
31,780 New
31,780 $53,000

Others Institutions Holding NXL

About Nexalin Technology, Inc.


  • Ticker NXL
  • Exchange
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,279,960
  • Market Cap $7.86M
More about NXL
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.